-
Something wrong with this record ?
Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine
A. Ligasová, R. Liboska, D. Friedecký, K. Mičová, T. Adam, T. Oždian, I. Rosenberg, K. Koberna,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NV15-31604A
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Freely Accessible Science Journals
from 2011-09-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
PubMed
26740587
DOI
10.1098/rsob.150172
Knihovny.cz E-resources
- MeSH
- Bromodeoxyuridine metabolism MeSH
- Cell Death MeSH
- Cell Nucleus metabolism MeSH
- Cytidine Deaminase metabolism MeSH
- Deoxycytidine analogs & derivatives metabolism MeSH
- Deoxyuridine analogs & derivatives metabolism MeSH
- DNA metabolism MeSH
- Humans MeSH
- RNA, Small Interfering metabolism MeSH
- Metabolome MeSH
- Cell Line, Tumor MeSH
- Antibodies metabolism MeSH
- DNA Replication MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
5-Ethynyl-2'-deoxyuridine (EdU) and 5-ethynyl-2'-deoxycytidine (EdC) are mainly used as markers of cellular replicational activity. Although EdU is employed as a replicational marker more frequently than EdC, its cytotoxicity is commonly much higher than the toxicity of EdC. To reveal the reason of the lower cytotoxicity of EdC, we performed a DNA analysis of five EdC-treated human cell lines. Surprisingly, not a single one of the tested cell lines contained a detectable amount of EdC in their DNA. Instead, the DNA of all the cell lines contained EdU. The content of incorporated EdU differed in particular cells and EdC-related cytotoxicity was directly proportional to the content of EdU. The results of experiments with the targeted inhibition of the cytidine deaminase (CDD) and dCMP deaminase activities indicated that the dominant role in the conversion pathway of EdC to EdUTP is played by CDD in HeLa cells. Our results also showed that the deamination itself was not able to effectively prevent the conversion of EdC to EdCTP, the conversion of EdC to EdCTP occurs with much lesser effectivity than the conversion of EdU to EdUTP and the EdCTP is not effectively recognized by the replication complex as a substrate for the synthesis of nuclear DNA.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000683
- 003
- CZ-PrNML
- 005
- 20201105083836.0
- 007
- ta
- 008
- 170103s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1098/rsob.150172 $2 doi
- 024 7_
- $a 10.1098/rsob.150172 $2 doi
- 035 __
- $a (PubMed)26740587
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Ligasová, Anna $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic anna.ligasova@upol.cz.
- 245 10
- $a Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine / $c A. Ligasová, R. Liboska, D. Friedecký, K. Mičová, T. Adam, T. Oždian, I. Rosenberg, K. Koberna,
- 520 9_
- $a 5-Ethynyl-2'-deoxyuridine (EdU) and 5-ethynyl-2'-deoxycytidine (EdC) are mainly used as markers of cellular replicational activity. Although EdU is employed as a replicational marker more frequently than EdC, its cytotoxicity is commonly much higher than the toxicity of EdC. To reveal the reason of the lower cytotoxicity of EdC, we performed a DNA analysis of five EdC-treated human cell lines. Surprisingly, not a single one of the tested cell lines contained a detectable amount of EdC in their DNA. Instead, the DNA of all the cell lines contained EdU. The content of incorporated EdU differed in particular cells and EdC-related cytotoxicity was directly proportional to the content of EdU. The results of experiments with the targeted inhibition of the cytidine deaminase (CDD) and dCMP deaminase activities indicated that the dominant role in the conversion pathway of EdC to EdUTP is played by CDD in HeLa cells. Our results also showed that the deamination itself was not able to effectively prevent the conversion of EdC to EdCTP, the conversion of EdC to EdCTP occurs with much lesser effectivity than the conversion of EdU to EdUTP and the EdCTP is not effectively recognized by the replication complex as a substrate for the synthesis of nuclear DNA.
- 650 _2
- $a protilátky $x metabolismus $7 D000906
- 650 _2
- $a bromodeoxyuridin $x metabolismus $7 D001973
- 650 _2
- $a buněčná smrt $7 D016923
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a buněčné jádro $x metabolismus $7 D002467
- 650 _2
- $a cytidindeaminasa $x metabolismus $7 D003564
- 650 _2
- $a DNA $x metabolismus $7 D004247
- 650 _2
- $a replikace DNA $7 D004261
- 650 _2
- $a deoxycytidin $x analogy a deriváty $x metabolismus $7 D003841
- 650 _2
- $a deoxyuridin $x analogy a deriváty $x metabolismus $7 D003857
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a metabolom $7 D055442
- 650 _2
- $a malá interferující RNA $x metabolismus $7 D034741
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Liboska, Radek $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, v.v.i., Prague 16610, Czech Republic.
- 700 1_
- $a Friedecký, David $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
- 700 1_
- $a Mičová, Kateřina $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
- 700 1_
- $a Adam, Tomáš, $d 1965- $7 xx0054162 $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
- 700 1_
- $a Oždian, Tomáš $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
- 700 1_
- $a Rosenberg, Ivan $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, v.v.i., Prague 16610, Czech Republic.
- 700 1_
- $a Koberna, Karel $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic karel.koberna@upol.cz.
- 773 0_
- $w MED00190574 $t Open biology $x 2046-2441 $g Roč. 6, č. 1 (2016), s. 150172
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26740587 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20201105083833 $b ABA008
- 999 __
- $a ok $b bmc $g 1179823 $s 961250
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 6 $c 1 $d 150172 $i 2046-2441 $m Open biology $n Open Biol $x MED00190574
- GRA __
- $a NV15-31604A $p MZ0
- LZP __
- $a Pubmed-20170103